Anti-inflammatory therapies from bedside to bench: Frameworks to support preclinical development.

The discovery of anti-inflammatory therapies is a top priority for people suffering from respiratory diseases. However, the limited clinical efficacy of new drugs-often not predicted in preclinical studies-underscores the need for improved evaluation…

Preview only. Read the full abstract at the source